The cost of access to HIV treatment.
Galatowitsch
Paul
P
Siegfried
Nandi
N
D000349:Africa; D019380:Anti-HIV Agents / Q000191:economics / Q000627:therapeutic use*; D016527:Drug Costs; D015658:HIV Infections / Q000188:drug therapy / Q000517:prevention & control*; D006679:HIV Seropositivity / Q000188:drug therapy*; D017048:Health Care Costs; D006801:Humans; D016032:Randomized Controlled Trials as Topic
D019380:Anti-HIV Agents